Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission

医学 哮喘 恶化 内科学 支气管扩张 嗜酸性 美波利祖马布 儿科 嗜酸性粒细胞 肺 病理
作者
Giovanna Elisiana Carpagnano,Andrea Portacci,Santi Nolasco,Aikaterini Detoraki,Alessandro Vatrella,Cecilia Calabrese,Corrado Pelaia,Francesca Montagnolo,Giulia Scioscia,Giuseppe Valenti,Maria D’Amato,Maria Filomena Caiaffa,Massimo Triggiani,Nicola Scichilone,Claudia Crimi
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:15: 1343362-1343362 被引量:33
标识
DOI:10.3389/fimmu.2024.1343362
摘要

Introduction Clinical remission (CliR) achievement has been recognized as a new potential outcome in severe asthma. Nevertheless, we still lack a detailed profile of what features could better identify patients undergoing clinical remission. In this study, we aim to address this issue, tracing a possible identikit of patients fulfilling remission criteria. Methods We enrolled 266 patients with severe eosinophilic asthma (SEA) treated with a 12-month course of anti-IL5/IL5 receptor (IL5r) monoclonal antibodies. Patients with no exacerbation, OCS withdrawal, ACT ≥ 20 and FEV 1 ≥ 80% after 1 year of biologic treatment were classified as in clinical remission. Results 30.5% of the enrolled patients achieved remission after biologic administration. CliR group showed a lower number of baseline asthma exacerbations and better lung function parameters, with a trend for higher ACT scores and a less frequent history of a positive skin prick test. CliR achievement was unlikely in presence of a higher BMI, a positive skin prick test, an increased number of asthma exacerbations before biologic treatment, anti-muscarinic administration, and a previous diagnosis of EGPA, bronchiectasis or osteoporosis. In contrast, a better lung function, an increased blood eosinophilic count, the presence of chronic rhinosinusitis with nasal polyps and a more frequent use of reliever therapy predicts remission development. Changes in exacerbations number, OCS use, ACT scores and FEV 1 % between remittent and non-remittent patients arise at specific follow up timepoints and are positively associated with CliR achievement. Discussion anti-IL5/IL5r biologics can induce CliR in a proportion of patients with SEA. Patients achieving remission demonstrate specific clinical, functional and inflammatory features, as well as a specific moment of improvement in all the CliR items.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美的安荷完成签到 ,获得积分10
刚刚
wwb完成签到,获得积分10
刚刚
刚刚
caitSith发布了新的文献求助10
刚刚
科研发疯人完成签到,获得积分10
2秒前
甜甜元槐发布了新的文献求助10
2秒前
井叙完成签到,获得积分10
2秒前
955完成签到,获得积分10
2秒前
2秒前
蓝天的应助被仓亓采纳,获得20
2秒前
乌拉拉发布了新的文献求助10
2秒前
FKKKKSY发布了新的文献求助10
2秒前
2秒前
3秒前
A11发布了新的文献求助10
3秒前
小鲨完成签到,获得积分10
3秒前
3秒前
3秒前
solace关注了科研通微信公众号
3秒前
3秒前
3秒前
3秒前
啵啵发布了新的文献求助10
4秒前
ZH完成签到 ,获得积分10
4秒前
4秒前
lattercomer完成签到 ,获得积分10
4秒前
4秒前
清风徐徐完成签到,获得积分10
4秒前
zz发布了新的文献求助10
4秒前
司徒南瓜饼完成签到,获得积分10
4秒前
5秒前
5秒前
5秒前
6秒前
田様的应助被陌路孤星采纳,获得10
6秒前
6秒前
zxxxx发布了新的文献求助10
6秒前
howdream完成签到,获得积分10
7秒前
as_eichi完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159542
求助须知:如何正确求助?哪些是违规求助? 9555044
关于积分的说明 21724263
捐赠科研通 7749434
什么是DOI,文献DOI怎么找? 3427246
关于科研通互助平台的介绍 2552263
邀请新用户注册赠送积分活动 2471618